DossierENTITY

RNAi therapeutics

Coverage of RNAi therapeutics in the Nexus archive.

Earliest in view: Jun 3 · 20:45 UTCMost recent: Jun 3 · 20:45 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJun 3 · 20:45 UTCSTAT NEWS
STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics
Alnylam partners with Inceptive Nucleics to develop AI foundation models for RNAi therapeutics. The three-year collaboration is worth up to $2 billion, with $30 million upfront in cash and equity. Jakob Uszkoreit, former Google researcher, co-founded Inceptive Nucleics after contributing to foundational AI research.